Search Results - "Johl, H."

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial by van Schaik, Ivo N, Bril, Vera, van Geloven, Nan, Lewis, Richard A, Sobue, Gen, Lawo, John-Philip, Mielke, Orell, Durn, Billie L, Cornblath, David R, George, K., Henderson, R., Van Damme, P., Demeestere, J., Larue, S., D'Amour, C., Breiner, A., Kunc, P., Sussova, J., Kalous, T., Talab, R., Bednar, M., Toomsoo, T., Sorro, U., Saarela, M., Auranen, M., Pouget, J., Attarian, S., Le Masson, G., Wielanek-Bachelet, A., Delmont, E., Aufauvre, D., Sommer, C., Kramer, D., Goerlitz, C., Haas, J., Chatzopoulos, M., Gold, R., Jaspert-Grehl, A., Kutschenko, A., Trebst, C., Baum, P., Bergh, F., Klehmet, J., Klostermann, F., Oechtering, J., Schroeter, M., Mueller, D., Sperfeld, A., Drory, V., Algom, A., Yarnitsky, D., Murinson, B., Ciccocioppo, F., Grandis, M., Lauria, G., Cazzato, D., Antonini, G., Morino, S., Cocito, D., Zibetti, M., Yokota, T., Ohkubo, T., Kanda, T., Kaida, K., Onoue, H., Kuwabara, S., Mori, M., Iijima, M., Baba, M., Yokoyama, K., van Schaik, I.N., Visser, N., Hoeijmakers, J., Rejdak, K., Casanovas Pons, C., Alberti Aguiló, M., Figueras, M., Marquez Infante, C., Benitez Rivero, S., Lunn, M., Morrow, J., Lavin, T., Melamed, I., Ajroud-Driss, S., Menichella, D., Dimachkie, M., Beydoun, S., Johl, H., Shtilbans, A., Ladha, S., Freimer, M., Kissel, J., Latov, N., Ubogu, E., Rao, T., Sharma, K., Gonzalez, G., Allen, J., Walk, D., Hobson-Webb, L.

“…Approximately two-thirds of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) need long-term intravenous immunoglobulin. Subcutaneous…”
Get full text

Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review by Lewis, Richard A., Cornblath, David R., Hartung, Hans‐Peter, Sobue, Gens, Lawo, John‐Philip, Mielke, Orell, Durn, Billie L., Bril, Vera, Merkies, Ingemar S. J., Bassett, Paul, Cleasby, Alexa, Schaik, Ivo N., Sabet, A, George, K, Roberts, L, Carne, R, Blum, S, Henderson, R, Van Damme, P, Demeestere, J, Larue, S, Kunc, P, Valis, M, Sussova, J, Kalous, T, Talab, R, Bednar, M, Toomsoo, T, Rubanovits, I, Gross‐Paju, K, Sorro, U, Saarela, M, Auranen, M, Pouget, J, Attarian, S, Wielanek, A, Desnuelle, C, Clavelou, P, Aufauvre, D, Schmidt, J, Kramer, D, Hoffmann, O, Goerlitz, C, Haas, J, Chatzopoulos, M, Berlit, P, Jaspert‐Grehl, A, Liebetanz, D, Baum, P, Bergh, F, Klehmet, J, Meisel, A, Lehmann, H, Schroeter, M, Hagenacker, T, Sperfeld, A, Drory, Israel V, Algom, A, Yarnitsky, D, Di Muzio, A, Mata, S, Schenone, A, Cazzato, D, Antonini, G, Morino, S, Zibetti, M, Ohkubo, T, Kaida, K, Onoue, H, Kuwabara, S, Mori, M, Ohyama, K, Baba, M, Akutsu, T, Kanai, K, Notermans, N C, Faber, C, Hoeijmakers, J, Rejdak, K, Chyrchel‐Paszkiewicz, U, Antonia, M, Gamez, J, Gosal, D, Lavin, T, Melamed, I, Testori, A, Menichella, D, Simpson, E, Johl, H, Lange, D, Shtilbans, A, Latov, N, Chin, R, Ubogu, E, Rao, T, MacDonald, P, Gonzalez, G, Allen, J, Hobson‐Webb, L, Gable, K

“…The Polyneuropathy And Treatment with Hizentra (PATH) study required subjects with chronic inflammatory demyelinating polyneuropathy (CIDP) to show dependency…”
Get full text

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies by Léger, Jean‐Marc, Geloven, Nan, Hartung, Hans‐Peter, Lewis, Richard A., Sobue, Gen, Lawo, John‐Philip, Durn, Billie L., Cornblath, David R., De Bleecker, Jan L., Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Tackenberg, Björn, Mielke, Orell, George, K., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J., D'Amour, C., Kunc, P., Valis, M., Sussova, J., Kalous, T., Toomsoo, T., Rubanovits, I., Gross‐Paju, K., Sorro, U., Saarela, M., Auranen, M., Attarian, S., Masson, G. Le, Wielanek‐Bachelet, A., Delmont, E., Zschuentzsch, J., Sommer, C., Kramer, D., Goerlitz, C., Haas, J., Chatzopoulos, M., Jaspert‐Grehl, A., Kutschenko, A., Trebst, C., Baum, P., Meisel, A., Klostermann, F., Oechtering, J., Lehmann, H., Mueller, D., Bethke, F., Drory, V., Algom, A., Sorbi, S., Mata, S., Schenone, A., Grandis, M., Cazzato, D., Ohkubo, T., Kuwabara, S., Mori, M., Ohyama, K., Baba, M., Nishiyama, K., Akutsu, T., Yokoyama, K., Kanai, K., van Schaik, I.N., Eftimov, F., Faber, C., Hoeijmakers, J., Rejdak, K., Chyrchel‐Paszkiewicz, U., Antonia, M., Salvado, M., Infante, C. Marquez, Benitez, S., Lunn, M., Morrow, J., Gosal, D., Lavin, T., Melamed, I., Ajroud‐Driss, S., Menichella, D., Barohn, R.J., Ladha, S., Freimer, M., Kissel, J., Chin, R., Mumfrey, S., Rao, T., MacDonald, P., Gonzalez, G., De Bleecker, J.L., Robberecht, W., Léger, J.‐M., Nguento, A., Schmidt, J., Kamienowski, J.

“…Intravenous immunoglobulin (IVIG) is a potential therapy for chronic inflammatory demyelinating polyneuropathy (CIDP). To investigate the efficacy and safety…”
Get full text

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study by Mielke, Orell, Cornblath, David R., Geloven, Nan, Hartung, Hans‐Peter, Lewis, Richard A., Durn, Billie, Shebl, Amgad, George, K., Roberts, L., Carne, R., Henderson, R., Van Damme, P., Larue, S., D'Amour, C., Kunc, P., Valis, M., Sussova, J., Kalous, T., Talab, R., Bednar, M., Toomsoo, T., Rubanovits, I., Gross‐Paju, K., Sorro, U., Auranen, M., Pouget, J., Le Masson, G., Wielanek‐Bachelet, A., Desnuelle, C., Clavelou, P., Aufauvre, D., Schmidt, J., Sommer, C., Kramer, D., Goerlitz, C., Haas, J., Gold, R., Berlit, P., Jaspert‐Grehl, A., Liebetanz, D., Kutschenko, A., Stangel, M., Trebst, C., Bergh, F., Klehmet, J., Klostermann, F., Oechtering, J., Lehmann, H., Bethke, F., Drory, V., Yarnitsky, D., Di Muzio, A., Sorbi, S., Mata, S., Grandis, M., Lauria, G., Antonini, G., Morino, S., Zibetti, M., Kanda, T., Kaida, K., Onoue, H., Mori, M., Iijima, M., Tomiyama, M., Akutsu, T., Yokoyama, K., Kanai, K., Eftimov, F., Notermans, N.C., Visser, N., Hoeijmakers, J., Rejdak, K., Chyrchel‐Paszkiewicz, U., Antonia, M., Salvado, M., Infante, C. Marquez, Benitez, S., Lunn, M., Morrow, J., Lavin, T., Melamed, I., Testori, A., Menichella, D., Simpson, E., Dimachkie, M., Beydoun, S., Lange, D., Shtilbans, A., Ladha, S., Freimer, M., Kissel, J., Rao, T., MacDonald, P., Sharma, K., Gonzalez, G., Allen, J., Walk, D., Hobson‐Webb, L., Gable, K.

“…In patients with chronic inflammatory demyelinating polyneuropathy (CIDP), intravenous immunoglobulin (IVIG) is recommended to be periodically reduced to…”
Get full text

Verteltoon as probleem in Gevaarlike land van Louis Krüger by A. A.E. Gouws, J. H. Johl

“…The issue of tone of narration in Louis Krüger’s novel Gevaarlike land Suspicion is cast on the literary expertise of the laureate novelist, Louis Krüger, by…”
Get full text

Altaegyptische Webestühle und Brettchenweberei in Altaegypten by Griffith, Nora, Johl, C. H.

Get full text

Duplex sonography in the diagnosis of peripheral arterial circulation disorders by Seifert, H, Jäger, K, Jöhl, H, Bollinger, A

“…From January 1984 to June 1986, 621 duplex scans of the arteries of the lower extremities were performed. 54.8% of the examinations were performed for clinical…”
Get more information